PT Multi Indocitra Tbk produces and trades in baby and health care products, and cosmetics in Indonesia.
Fair value with mediocre balance sheet.
Share Price & News
How has Multi Indocitra's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: QF9 has not had significant price volatility in the past 3 months.
7 Day Return
DE Retail Distributors
1 Year Return
DE Retail Distributors
Return vs Industry: QF9 underperformed the German Retail Distributors industry which returned 21.1% over the past year.
Return vs Market: QF9 underperformed the German Market which returned 15.1% over the past year.
Price Volatility Vs. Market
How volatile is Multi Indocitra's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Multi Indocitra undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: QF9 (€0.02) is trading above our estimate of fair value (€0)
Significantly Below Fair Value: QF9 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: QF9 is good value based on its PE Ratio (6.2x) compared to the Retail Distributors industry average (13.4x).
PE vs Market: QF9 is good value based on its PE Ratio (6.2x) compared to the German market (20.9x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate QF9's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: QF9 is good value based on its PB Ratio (0.3x) compared to the XE Retail Distributors industry average (1.6x).
How is Multi Indocitra forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Retail industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Multi Indocitra has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine whether Multi Indocitra is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- Multi Indocitra competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Retail industry.
How has Multi Indocitra performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: QF9 has a large one-off gain of IDR13.8B impacting its September 30 2019 financial results.
Growing Profit Margin: QF9's current net profit margins (4.6%) are lower than last year (5.5%).
Past Earnings Growth Analysis
Earnings Trend: QF9's earnings have grown by 6.4% per year over the past 5 years.
Accelerating Growth: QF9's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: QF9 had negative earnings growth (-2.4%) over the past year, making it difficult to compare to the Retail Distributors industry average (-1.9%).
Return on Equity
High ROE: QF9's Return on Equity (4.9%) is considered low.
Return on Assets
Return on Capital Employed
How is Multi Indocitra's financial position?
Financial Position Analysis
Short Term Liabilities: QF9's short term assets (IDR475.9B) exceed its short term liabilities (IDR293.6B).
Long Term Liabilities: QF9's short term assets (IDR475.9B) exceed its long term liabilities (IDR72.5B).
Debt to Equity History and Analysis
Debt Level: QF9's debt to equity ratio (39.5%) is considered satisfactory.
Reducing Debt: QF9's debt to equity ratio has increased from 11.1% to 39.5% over the past 5 years.
Debt Coverage: QF9's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: QF9's interest payments on its debt are not well covered by EBIT (2.1x coverage).
Inventory Level: QF9 has a high level of physical assets or inventory.
Debt Coverage by Assets: QF9's debt is covered by short term assets (assets are 1.9x debt).
What is Multi Indocitra's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: QF9's dividend (2.89%) is higher than the bottom 25% of dividend payers in the German market (1.31%).
High Dividend: QF9's dividend (2.89%) is low compared to the top 25% of dividend payers in the German market (3.59%).
Stability and Growth of Payments
Stable Dividend: QF9's dividend payments have been volatile in the past 10 years.
Growing Dividend: QF9's dividend payments have fallen over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (17.8%), QF9's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Anthony Honoris (36yo)
Mr. Anthony Honoris has been a Director of PT Multi Indocitra Tbk since may 2013. Mr. Honoris graduated from melbourne university of business management in 2005.
|President Director||4.8yrs||no data||0.14% IDR18.9k|
|President Commissioner||7.8yrs||no data||no data|
|Independent Commissioner||11.8yrs||no data||no data|
|Independent Director||7.3yrs||no data||no data|
|Commissioner||7.8yrs||no data||no data|
|Independent Director||5.5yrs||no data||no data|
Experienced Board: QF9's board of directors are considered experienced (7.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
PT Multi Indocitra Tbk's company bio, employee growth, exchange listings and data sources
- Name: PT Multi Indocitra Tbk
- Ticker: QF9
- Exchange: DB
- Founded: 1990
- Industry: Distributors
- Sector: Retail
- Market Cap: Rp206.016b
- Listing Market Cap: Rp13.879m
- Shares outstanding: 595.42m
- Website: https://www.mic.co.id
Number of Employees
- PT Multi Indocitra Tbk
- Green Central City
- 6th Floor
- West Jakarta
- Jakarta Raya
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|MICE||IDX (Indonesia Stock Exchange)||Yes||Common Stock||ID||IDR||Dec 2005|
|QF9||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Dec 2005|
PT Multi Indocitra Tbk produces and trades in baby and health care products, and cosmetics in Indonesia. It offers bottle teats, pacifiers, breast pumps, baby toiletries, diapers, wet wipes, and toys, as well as a range of products for senior citizens under the Pigeon brand name. The company also provides kitchen and houseware items, such as plastic airtight containers under the Lock&Lock brand name. In addition, it is involved in the retail sale of baby products. The company offers its products through its own distribution centers, as well as third party suppliers and sub-distributors. The company was founded in 1990 and is based in West Jakarta, Indonesia.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/18 21:20|
|End of Day Share Price||2020/02/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.